NF1 and neoplasm: Stage IVdisease was more common in NF1 patients (15%) than those with sporadic tumours(9%) but NF1 was still associated with a significantly worse 5-year survival ifpatients with stage IV disease were removed from the analysis (33% versus 63%; P = .015)(see Figure 2).